J05AE Protease inhibitors, direct acting antivirals
ATC group of level 4 – chemical subgroup · in plain English: medicines against viruses, e.g. HIV or hepatitis
This site has the patient leaflet or the SPC of 75 medicines in this group and its subgroups.
- 30 prescription only (POM)
- 41 no longer supplied or not available
Place in the ATC classification
How to read ATC codes – what the levels mean and what a code does not tell you.
- J Antiinfectives for systemic use 1,393 medicines
- J05 Antivirals for systemic use 392 medicines
- J05A Direct acting antivirals 392 medicines
-
J05AE Protease inhibitors, direct acting antivirals 75 medicines
- J05AE01 saquinavir 1 medicine
- J05AE02 indinavir 1 medicine
- J05AE03 ritonavir 5 medicines
- J05AE04 nelfinavir 1 medicine
- J05AE05 amprenavir 1 medicine
- J05AE07 fosamprenavir 3 medicines
- J05AE08 atazanavir 24 medicines
- J05AE09 tipranavir 1 medicine
- J05AE10 darunavir 36 medicines
-
J05AE Protease inhibitors, direct acting antivirals 75 medicines
- J05A Direct acting antivirals 392 medicines
- J05 Antivirals for systemic use 392 medicines
Active substances in the group
- Amprenavir 1 medicine
- Atazanavir 24 medicines
- Boceprevir 1 medicine
- Darunavir 36 medicines
- Fosamprenavir 3 medicines
- Indinavir sulfate ethanolate 1 medicine
- Nelfinavir 1 medicine
- Ritonavir 5 medicines
- Saquinavir 1 medicine
- Telaprevir 1 medicine
- Tipranavir 1 medicine
Medicines in the group and its subgroups
Other groups of the same level
- J05AB Nucleosides and nucleotides excl. reverse transcriptase inhibitors 40 medicines
- J05AD Phosphonic acid derivatives, direct acting antivirals 2 medicines
- J05AF Nucleoside and nucleotide reverse transcriptase inhibitors 82 medicines
- J05AG Non-nucleoside reverse transcriptase inhibitors 32 medicines
- J05AH Neuraminidase inhibitors, direct acting antivirals 14 medicines
- J05AJ Integrase Inhibitors, antiinfectives for systematic use 15 medicines
- J05AP Antivirals for treatment of HCV infections 25 medicines
- J05AR Antivirals for treatment of HIV infections, combinations 80 medicines
- J05AX Other antivirals 27 medicines
Other names of the ATC group
- Czech: J05AE Inhibitory proteáz
- French: J05AE inhibiteurs de protéase
- German: J05AE Proteasehemmer
- German: J05AE Proteasehemmer
- Italian: J05AE INIBITORI DELLE PROTEASI
- Polish: J05AE Inhibitory proteazy
- Turkish: J05AE Proteaz inhibitörleri, doğrudan etkili antiviraller
- Portuguese (Brazil): J05AE Inibidores da protease
- German (Switzerland): J05AE Proteasehemmer
- French (Switzerland): J05AE Inhibiteurs de protéase
- Italian (Switzerland): J05AE Inibitori delle proteasi
- Dutch: J05AE Proteaseremmers, direct werkende antivirale middelen
- English (Canada): J05AE Protease inhibitors, direct acting antivirals
Sources
- Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
- Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
- World Health Organization (WHO): ATC/DDD classification, group J05AE
Contains public sector information licensed under the Open Government Licence v3.0.
Ask your doctor or pharmacist which medicine is right for you.
